IGF1 and atherosclerosis: This study suggests that AGE-modified FN modulates SMC’s response to IGF-I and PDGF-BB, both present in the vascular wall, potentially contributing to the pathogenesis of diabetes associated atherosclerosis by increasing SMC susceptibility to IGF-I mitogenic effects.